Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Multiple Myeloma
|
0.700 | GeneticVariation | CLINVAR | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. | 26619011 | 2016 | |||||
Adenocarcinoma of lung (disorder)
|
0.700 | GeneticVariation | CLINVAR | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. | 26619011 | 2016 | |||||
Multiple Myeloma
|
0.700 | GeneticVariation | CLINVAR | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. | 26619011 | 2016 | |||||
Glioblastoma
|
0.700 | GeneticVariation | CLINVAR | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. | 26619011 | 2016 | |||||
Glioblastoma
|
0.700 | GeneticVariation | CLINVAR | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. | 26619011 | 2016 | |||||
Adenocarcinoma of lung (disorder)
|
0.700 | GeneticVariation | CLINVAR | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. | 26619011 | 2016 | |||||
Transitional cell carcinoma of bladder
|
0.700 | GeneticVariation | CLINVAR | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. | 26619011 | 2016 | |||||
Transitional cell carcinoma of bladder
|
0.700 | GeneticVariation | CLINVAR | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. | 26619011 | 2016 | |||||
Colorectal Neoplasms
|
0.700 | CausalMutation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 | |||||
melanoma
|
0.700 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 | |||||
Colorectal Neoplasms
|
0.700 | CausalMutation | CLINVAR | The road to resistance: EGFR mutation and cetuximab. | 22310681 | 2012 | |||||
Colorectal Neoplasms
|
0.700 | CausalMutation | CLINVAR | Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer. | 22180495 | 2012 | |||||
Colorectal Neoplasms
|
0.700 | CausalMutation | CLINVAR | Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? | 21129611 | 2010 | |||||
Colorectal Neoplasms
|
0.700 | CausalMutation | CLINVAR | Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. | 20350999 | 2010 | |||||
Colorectal Neoplasms
|
0.700 | CausalMutation | CLINVAR | Clinical biomarkers in oncology: focus on colorectal cancer. | 19537845 | 2009 | |||||
Colorectal Neoplasms
|
0.700 | CausalMutation | CLINVAR | Mutations of the BRAF gene in human cancer. | 12068308 | 2002 | |||||
Adenocarcinoma of large intestine
|
0.700 | GeneticVariation | UNIPROT |